Benitec Biopharma Ltd Stock Analysis

Benitec Stock Analysis Notes

About 46.0% of the company shares are held by institutions such as insurance companies. The book value of Benitec Biopharma was currently reported as 4.68. The company recorded a loss per share of 5.51. Benitec Biopharma last dividend was issued on the 18th of November 2019. The entity had 1:17 split on the 26th of July 2023. Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company was incorporated in 1995 and is headquartered in Hayward, California. Benitec Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 18 people. For more info on Benitec Biopharma Ltd please contact the company at 510 780 0819 or go to https://benitec.com.

Benitec Biopharma Investment Alerts

Benitec Biopharma Upcoming and Recent Events

Benitec Largest EPS Surprises

View All Earnings Estimates

Benitec Biopharma Environmental, Social, and Governance (ESG) Scores

Benitec Stock Institutional Investors

Note, although Benitec Biopharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Benitec Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 215.39 M.

Benitec Profitablity

Management Efficiency

Benitec Biopharma has return on total asset (ROA) of (0.496) % which means that it has lost $0.496 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9168) %, meaning that it created substantial loss on money invested by shareholders. Benitec Biopharma's management efficiency ratios could be used to measure how well Benitec Biopharma manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.5. In addition to that, Return On Capital Employed is expected to decline to -0.57. At present, Benitec Biopharma's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 147.3 K, whereas Non Current Assets Total are forecasted to decline to about 583.5 K.

Technical Drivers

As of the 25th of March, Benitec Biopharma shows the Risk Adjusted Performance of 0.0668, downside deviation of 4.81, and Mean Deviation of 3.44. Benitec Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Benitec Biopharma Price Movement Analysis

Benitec Biopharma Insider Trading Activities

Benitec Biopharma Outstanding Bonds

Benitec Biopharma Predictive Daily Indicators

Benitec Biopharma Corporate Filings

Benitec Biopharma Forecast Models

Benitec Biopharma's time-series forecasting models are one of many Benitec Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Benitec Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Benitec Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Benitec shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Benitec Biopharma. By using and applying Benitec Stock analysis, traders can create a robust methodology for identifying Benitec entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Benitec analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Benitec analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Benitec Biopharma Ltd stock analysis indicators help investors evaluate how Benitec Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Benitec Biopharma shares will generate the highest return on investment. By understating and applying Benitec Biopharma stock analysis, traders can identify Benitec Biopharma position entry and exit signals to maximize returns.

When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.